NEW ENGLAND SECURITIES CORP /MA/ - NOVABAY PHARMACEUTICALS INC ownership

NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P102. A total of 23 filers reported holding NOVABAY PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NEW ENGLAND SECURITIES CORP /MA/ ownership history of NOVABAY PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$0
-100.0%
6000.0%0.00%
Q3 2014$1,0006000.0%0.00%
Q2 2014$0
-100.0%
600
-50.0%
0.00%
Q1 2014$2,0001,2000.00%
Other shareholders
NOVABAY PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
GARRISON BRADFORD & ASSOCIATES INC 138,000$170,0000.16%
BUCKINGHAM STRATEGIC WEALTH, LLC 56,583$70,0000.03%
EXENCIAL WEALTH ADVISORS, LLC 59,679$71,0000.03%
Orbitronix, LP 25,100$31,0000.02%
DRW Securities, LLC 183,988$226,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 121,500$149,0000.01%
EP Wealth Advisors, LLC 13,267$16,0000.00%
GLENMEDE TRUST CO NA 300,000$369,0000.00%
KCM INVESTMENT ADVISORS LLC 23,333$29,0000.00%
BOSTON FAMILY OFFICE LLC 17,500$22,0000.00%
View complete list of NOVABAY PHARMACEUTICALS INC shareholders